Stocktoria
IRIDEX CORP IRIX
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1996-02-16
IRIDEX CORP financials (annual, from 10-K)
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $52.7M | $48.7M | $51.9M | $57.0M | $53.9M |
| Gross profit | $19.2M | $19.5M | $21.8M | $25.4M | $22.8M |
| R&D expense | $3.7M | $5.4M | $6.8M | $7.2M | $6.9M |
| Operating income | -$2.6M | -$8.3M | -$10.0M | -$7.5M | -$7.5M |
| Income tax | $57,000 | $68,000 | $90,000 | $65,000 | $40,000 |
| Net income | -$4.4M | -$8.9M | -$9.6M | -$7.5M | -$5.2M |
| EPS (diluted) | $-0.26 | $-0.54 | $-0.59 | $-0.47 | $-0.34 |
| Operating cash flow | -$2.1M | -$7.3M | -$6.7M | -$9.5M | $8.2M |
| Free cash flow | -$2.3M | -$7.3M | -$6.9M | -$9.8M | $8.0M |
| Cash & equivalents | $6.0M | $2.4M | $7.0M | $13.9M | $23.9M |
| Inventory | $7.9M | $10.8M | $9.9M | $10.6M | $7.6M |
| Total assets | $29.2M | $29.1M | $34.4M | $42.3M | $48.7M |
| Total liabilities | $24.2M | $27.0M | $24.9M | $25.1M | $25.4M |
| Shareholders' equity | $4.9M | $2.1M | $9.5M | $17.2M | $23.3M |
Source: SEC EDGAR filings · CIK 0001006045 · as of 2026-01-03. Facts from filings plus Stocktoria's own computed scores — not investment advice.